Do extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction?
Extracellular vesicles from human cardiac progenitor cells offer a potential cell-free approach to improve cardiac function and inhibit apoptosis after myocardial infarction.
EVs are the active component of the paracrine secretion by human CPCs. As a cell-free approach, EVs could circumvent many of the limitations of cell transplantation.
Barile et al. (Fri,) studied this question.